ANDA 211869, held by Fresenius Kabi USA. Isosulfan Blue.
As of Nov 16, 2026, ANDA 211869 (Isosulfan Blue), held by Fresenius Kabi USA, was first approved by FDA on Sep 8, 2022, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 8, 2022 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Isosulfan Blue50MG/5ML (10MG/ML) ยท solution;subcutaneous | Isosulfan Blue | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters